Common Stock, Shares, Outstanding of Summit Therapeutics Inc. from 31 Jan 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Summit Therapeutics Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Jan 2018 to 31 Dec 2025.
  • Summit Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 775,371,200, a 5.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Summit Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 775,371,200 +37,745,196 +5.1% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 744,442,533 +7,347,568 +1% 30 Sep 2025 10-Q 20 Oct 2025 2025 Q3
Q2 2025 742,806,672 +18,486,471 +2.6% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 741,609,390 +39,634,794 +5.6% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 737,626,004 +35,965,951 +5.1% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 737,094,965 +39,243,657 +5.6% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 724,320,201 +26,634,836 +3.8% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 701,974,596 +4,289,231 +0.62% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 701,660,053 +490,568,628 +232% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q3 2023 697,851,308 +496,530,133 +247% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 697,685,365 +599,563,009 +611% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 697,685,365 +599,563,009 +611% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 211,091,425 +113,051,885 +115% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 201,321,175 +103,692,664 +106% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 98,122,356 +770,557 +0.79% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 98,122,356 +15,202,834 +18% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 98,039,540 +15,464,476 +19% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 97,628,511 +30,396,608 +45% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 97,351,799 +30,119,899 +45% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 82,919,522 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 82,575,064 +15,397,010 +23% 31 Dec 2020 10-K/A 21 Dec 2022 2021 FY
Q3 2020 67,231,903 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 67,231,900 30 Jun 2020 8-K 29 Sep 2020 2020 Q2
Q4 2019 67,178,054 +35,100,080 +109% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 32,077,974 +17,365,250 +118% 31 Jan 2019 8-K 29 Sep 2020 2020 Q2
Q4 2017 14,712,724 31 Jan 2018 8-K 29 Sep 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.